US Archives - IMAA – Institute for Mergers, Acquisitions, and Alliances

Deal Capsule: Transactions In Chemicals & Pharmaceuticals July 2016

November 29, 2021August 5, 2016 by Christopher Kummer

by KPMG
The number of completed deals remained high in both sectors in HY1 2016. While total deal value for pharmaceuticals decreased, chemicals witnessed a 40% increase in HY1 2016 versus HY1 2015. Pharmaceutical M&A was impacted by stock market volatility, while new US regulatory rules struck down the $160 billion Pfizer-Allergan merger. Oncology and dermatology were key areas of interest for big pharma, who were especially keen on acquiring biotech assets. […] Read more

Managing Intangible Property Of Japanese Multinational Companies In M&A Context

August 21, 2023June 15, 2016 by Christopher Kummer

by KPMG
In recent years, Japanese multinational companies have been acquiring an increasing number of foreign companies or divisions of companies. Although the acquisition of existing foreign companies or business divisions has been an effective means for Japanese multinational companies to quickly expand their business into foreign and new markets, it has created difficulties related to integrating the management of the acquired foreign companies or business divisions. […] Read more

Global Capital Confidence Barometer – Buying And Bonding: Alliances Join M&A As Engines Of Growth

August 21, 2023April 23, 2016 by Christopher Kummer

by Ernst & Young
Our latest Global Capital Confidence Barometer continues to find a strong acquisition appetite together with a growing inclination to forge new alliances. Prolonged economic challenges are driving investment decisions, leading companies to ally and cooperate to generate growth as well as compete and acquire to gain market share. […] Read more

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

August 21, 2023April 20, 2016 by Christopher Kummer

by KPMG
While the number of completed pharma deals were slightly higher in Q1 2016 versus Q1 2015, deal value was far lower in the absence of any >$10 billion completions. Only one deal exceeded $5 billion in Q1 2016 (versus 8 in Q1 2015). Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. Declines in transaction values were also witnessed in chemicals. Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. […] Read more

Global Oil And Gas Transactions Review 2015

August 21, 2023January 27, 2016 by Christopher Kummer

by Ernst & Young
The dramatic drop in both crude oil and natural gas prices across the year combined with a high level of uncertainty about their future trajectory challenged oil and gas merger and acquisition (M&A) activity in 2015. Crude oil prices, which began the year at US$55 per barrel (Brent), declined to US$37 per barrel by December, the lowest level since May 2004 with natural gas prices experiencing a similar journey. […] Read more

2016 Global Chemical Industry Mergers And Acquisitions Outlook: A Quest For Focus

November 29, 2021January 22, 2016 by Christopher Kummer

by Deloitte
In the Deloitte Touche Tohmatsu Limited (Deloitte Global) 2015 Global chemical industry mergers and acquisitions outlook, record levels of chemical mergers and acquisitions (M&A) activity in 2014 were observed, with a prediction that strong M&A momentum would continue in the industry into 2015. While the number of global chemical deals was relatively flat in 2015, the strong M&A momentum has continued with the number of global chemical deals in 2015 exceeding the previous six-year average by over 6 percent. […] Read more

An Appetite For M&A: How Food Companies Can Buy And Sell Their Way To Competitive Advantage

July 18, 2022January 19, 2016 by Christopher Kummer

Exhibit 2 Food company performance – 2010 to 2013

by Strategy&
Food companies, faced with new and challenging market forces, are changing their strategic approach to growth. For many, this is underscored by a focus on capabilities as a driver of how to organize and operate their businesses for competitive advantage. For winning companies, this focus on capabilities is informing their growth path, including how they approach mergers, acquisitions, and divestitures. […] Read more

Consumer Currents – Food For Thought: Do Grocers Need To Reinvent Their Business Model?

November 29, 2021December 17, 2015 by Christopher Kummer

by KPMG
As Albert Einstein shrewdly remarked: “If you always do what you always did, you will always get what you always got.” In the consumer marketplace in the 21st century we live in an age where innovation and reinvention is the key to growth. That is the challenge – and opportunity. […] Read more

Cross-Border Deal Making In The High-Tech Industry: Lessons Learned From An M&A Transaction

June 23, 2023May 15, 2015 by Christopher Kummer

by Willis Towers Watson
With merger and acquisition (M&A) activity heating up worldwide, two Towers Watson M&A experts met with Karen Gaydon, a successful U.S.-based deal maker whose team at Synaptics recently closed the acquisition of a joint venture in Japan. This article, which summarizes their discussion, includes insights from all three on M&A trends in the high-tech industry, as well as valuable information about M&A success factors. […] Read more

Are you sure youwant to log out?

Are you sure you
want to log out?